AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglyn M 50mg/1000mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglyn M 50mg/1000mg Tablet PR

Diabetics with type 2 mellitus may find relief from elevated blood glucose levels with the dual-action formulation of Sitaglyn M 50mg/1000mg Tablet PR. This medication effectively mitigates the risk of severe diabetic complications like renal impairment and vision loss, and may lessen the probability of cardiovascular events. Sitaglyn M 50mg/1000mg Tablet PR can be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose readings, and concurrent medications. Consuming this medication with meals minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management. Lifestyle choices significantly influence glycemic control. Commonly reported adverse effects encompass diarrhea, nausea, emesis, dyspepsia, cephalalgia, and pharyngitis. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, requires awareness and preparedness. Prior to initiating therapy, patients should inform their physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions necessitate comprehensive disclosure of all medications to the prescribing physician. Alcohol intake should be minimized due to its hypoglycemic effects. Regular monitoring of renal function and blood glucose levels will be conducted throughout treatment.

Uses of Sitaglyn M 50mg/1000mg Tablet PR

Managing type 2 diabetes

Major Benefits of Sitaglyn M 50mg/1000mg Tablet PR:

Follow your doctor's instructions or the product label for proper usage. Take Sitaglyn M 50mg/1000mg Tablet PR with meals.

Common Side effects of Sitaglyn M 50mg/1000mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglyn M 50mg/1000mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Sitaglyn M 50mg/1000mg Tablet PR with a meal.

How Sitaglyn M 50mg/1000mg Tablet PR works:

Sitaglyn M 50mg/1000mg tablets are a dual-action formulation combining sitagliptin and metformin. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, acts by reducing liver glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness. This synergistic effect results in superior blood glucose management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglyn M 50mg/1000mg Tablet PR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitaglyn M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaglyn M 50mg/1000mg tablets during breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitaglyn M 50mg/1000mg Tablet PR, potentially requiring dosage modification. Consultation with a physician is recommended. The use of Sitaglyn M 50mg/1000mg Tablet PR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Sitaglyn M 50mg/1000mg Tablet PR is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitaglyn M 50mg/1000mg Tablet PR :

Should you forget a dose of Sitaglyn M 50mg/1000mg PR Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sitaglyn M 50mg/1000mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaglyn M 50mg/1000mg Tablet PR

Sitaglyn M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitaglyn M 50mg/1000mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Sitaglyn M 50mg/1000mg Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Patients with known allergies to Sitaglyn M 50mg/1000mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaglyn M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitagliptin/Metformin (Sitaglyn M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglyn M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 50mg/1000mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitaglyn M 50mg/1000mg Tablet PR components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitaglyn M 50mg/1000mg tablets is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50mg/1000mg) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglyn M 50mg/1000mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely, ensuring it's inaccessible to children, pets, and others.
Sitaglyn M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitaglyn M 50mg/1000mg Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitaglyn M 50mg/1000mg Tablet PR components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaglyn M 50mg/1000mg Tablet PR with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglyn M 50mg/1000mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaglyn M 50mg/1000mg Ta...
143